Levorphanol Tartrate Tablet
Product Images NDC 0527-3237

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Levorphanol Tartrate (NDC 0527-3237). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lannett Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Levorphanol Tartrate Tablets Usp 1)

Chemical structure of Levorphanol Tartrate, showing the molecular arrangement of the active ingredient Levorphanol combined with tartrate and associated water molecules (dihydrate).*

FDA Label Image

2 mg Bottle Label (Levorphanol Tartrate Tablets Usp 2)

Label for Levorphanol Tartrate Tablets USP containing 2 mg of levorphanol tartrate per tablet. The label indicates a quantity of 100 tablets, prescription use only, and storage instructions of 20° to 25°C (68° to 77°F). Distributed by Lannett Company, Inc. with NDC 0527-3236-37.*

FDA Label Image

Levorphanol Tartrate Tablets Usp 3

Packaging label for Levorphanol Tartrate Tablets, USP 3 mg, oral tablets by Lannett Company, Inc. The label shows an NDC of 0527-3237-37 and indicates the product contains 3 mg of levorphanol tartrate per tablet. The package contains 100 tablets and includes storage instructions and a pharmacist advisory to dispense the enclosed medication guide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.